ROVIDA, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.833
EU - Europa 4.068
AS - Asia 686
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 9.591
Nazione #
US - Stati Uniti d'America 4.800
PL - Polonia 2.126
IE - Irlanda 501
IT - Italia 476
SE - Svezia 470
HK - Hong Kong 225
CN - Cina 162
JO - Giordania 132
FI - Finlandia 83
GB - Regno Unito 81
VN - Vietnam 80
DE - Germania 77
BE - Belgio 71
UA - Ucraina 71
IN - India 41
AT - Austria 37
CA - Canada 33
CH - Svizzera 29
SG - Singapore 12
TR - Turchia 11
RU - Federazione Russa 10
FR - Francia 8
MK - Macedonia 8
KR - Corea 6
ES - Italia 5
TW - Taiwan 5
NL - Olanda 4
PH - Filippine 4
RO - Romania 3
AL - Albania 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HU - Ungheria 1
LY - Libia 1
MY - Malesia 1
RS - Serbia 1
Totale 9.591
Città #
Warsaw 2.126
Fairfield 754
Chandler 538
Dublin 496
Ashburn 386
Woodbridge 370
Seattle 328
Cambridge 290
Houston 265
Wilmington 243
Ann Arbor 205
Florence 187
Jacksonville 149
Hong Kong 132
Princeton 119
Lawrence 110
Altamura 104
Beijing 100
Boston 84
Dong Ket 72
Brussels 71
Boardman 63
Buffalo 59
San Diego 55
Falls Church 39
Medford 39
Pune 33
Shanghai 33
Vienna 30
Bern 28
Norwalk 21
Ottawa 18
Phoenix 17
Redwood City 14
Toronto 14
Dearborn 12
Singapore 12
Andover 11
London 11
Rome 10
Milan 8
Moscow 8
Hillsboro 7
Redmond 7
Izmir 6
Prato 6
Dallas 5
Laurel 5
Renton 5
Siena 5
Tappahannock 5
Barcelona 4
Cagliari 4
Cisano Bergamasco 4
Costa Mesa 4
Guangzhou 4
Notre Dame 4
Castelliri 3
Daan 3
Detroit 3
Foggia 3
Fuzhou 3
Hounslow 3
Kilburn 3
Lynchburg 3
Menlo Park 3
Mumbai 3
New York 3
Ohrid 3
Anghiari 2
Augusta 2
Bologna 2
Bremen 2
Düsseldorf 2
Fremont 2
Garden Grove 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Kochi 2
Lappeenranta 2
Munich 2
Pavia 2
Poggio a Caiano 2
Prescot 2
Rho 2
Rubano 2
San Juan 2
San Mateo 2
Sesto Fiorentino 2
Silea 2
Trumbull 2
Turin 2
Acireale 1
Acton 1
Arezzo 1
Atlanta 1
Auburn Hills 1
Austin 1
Baotou 1
Totale 7.830
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 271
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 258
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 249
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 245
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 239
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 231
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 224
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 222
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 219
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 218
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 216
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 215
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 203
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 195
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 180
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 165
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 150
Impact of ERK5 on the Hallmarks of Cancer 145
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 137
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 126
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 126
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 125
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 117
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 114
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 110
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 100
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 98
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 98
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 94
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 94
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 93
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 92
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 92
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 92
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 90
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 90
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 89
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 87
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 86
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 85
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 84
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 84
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 84
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 80
Tryptophan availability selectively limits NO-synthase induction in macrophages. 80
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 80
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 80
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 79
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 78
Fatty acids regulate the biology of cholangiocarcinoma cells 77
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 77
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 77
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 76
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 76
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 76
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 75
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 73
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 71
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 70
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 68
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 67
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 67
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 67
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 67
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 65
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 61
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 58
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 57
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 57
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 54
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 54
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 53
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 53
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 50
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 49
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 49
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 48
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 47
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 46
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 46
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 46
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 45
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 45
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 45
TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. 44
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 44
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 43
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 42
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 40
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 40
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 39
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 39
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 39
Effects of a human myeloid chronic leukemia cell line (K562) on in vivo angiogenesis 38
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 38
ERK5 inhibition elicits cellular senescence in human melanoma cells 38
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 36
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 34
ERK5 MEDIATES THE MACROPHAGE COLONY-STIMULATING FACTOR SIGNALLING IN A SRC-DEPENDENT AND PKC- INDEPENDENT FASHION 33
Expression and Role in the Proliferation of the Colony-Stimulating Factor-1 Receptor in Breast Cancer Cells 32
Totale 9.540
Categoria #
all - tutte 24.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019720 0 0 0 0 0 0 0 0 68 140 279 233
2019/20202.179 146 180 77 155 251 242 224 286 205 155 210 48
2020/20211.475 133 155 50 157 69 164 77 109 143 205 83 130
2021/2022940 59 66 44 56 50 54 49 54 68 59 140 241
2022/20232.318 189 366 125 159 155 382 349 153 287 22 77 54
2023/2024756 38 93 126 43 69 114 54 200 19 0 0 0
Totale 9.792